27 results
10-K
2023 FY
EX-4.7
PLX
Protalix BioTherapeutics Inc.
Annual report
14 Mar 24
7:03am
10-K
2022 FY
EX-4.7
PLX
Protalix BioTherapeutics Inc.
Annual report
27 Feb 23
6:45am
S-8
EX-4.1
PLX
Protalix BioTherapeutics Inc.
14 Jul 22
Registration of securities for employees
4:31pm
S-3
EX-4.4
PLX
Protalix BioTherapeutics Inc.
Shelf registration
20 Apr 22
4:49pm
S-3
EX-4.3
PLX
Protalix BioTherapeutics Inc.
Shelf registration
20 Apr 22
4:49pm
8-K
EX-4.1
lwxgcwk
26 Aug 21
Protalix BioTherapeutics Announces Closing of Private Note Exchange
7:16am
8-K
EX-4.2
ffc6 rxtz08kzsah
26 Aug 21
Protalix BioTherapeutics Announces Closing of Private Note Exchange
7:16am
8-K
EX-4.3
pes9c
26 Aug 21
Protalix BioTherapeutics Announces Closing of Private Note Exchange
7:16am
8-K
EX-4.1
cov8e28h1cf dkaoywy
12 Mar 20
Protalix BioTherapeutics Announces $43.7 Million in Financing to
8:04am
8-K
EX-4.1
k58qcoe6e93ypa8ab
1 Dec 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.2
y0gla su8l
25 Jul 17
Protalix BioTherapeutics Completes Private Note Exchange of $9 million Notes Maturing September 2018 for $8.55 million Notes Maturing February 2022
12:00am
8-K
EX-4.1
z0la llce7hunotkp
25 Jul 17
Protalix BioTherapeutics Completes Private Note Exchange of $9 million Notes Maturing September 2018 for $8.55 million Notes Maturing February 2022
12:00am
8-K
EX-4.4
84izdv6 dwzc0
25 Jul 17
Protalix BioTherapeutics Completes Private Note Exchange of $9 million Notes Maturing September 2018 for $8.55 million Notes Maturing February 2022
12:00am
8-K
EX-4.2
7jfxqe0od42zc 7a22
7 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.3
yeu88sxhx 7atdvpuna
7 Dec 16
Entry into a Material Definitive Agreement
12:00am